Danish Diabetes Academy Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02881060
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Danish Diabetes Academy

Active Ingredients

Drugs in Phase 4 Trials (2)

ethanol (1 trial)

glucagon (1 trial)

Drugs in Phase 2 Trials (1)

spermidine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Hypoglycemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3